Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Deficit)

v3.21.2
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
Total
Common Stock
Preferred Stock
Series A Preferred Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2019   67,105,000 0      
Beginning balance at Dec. 31, 2019 $ (34,913,110) $ 67,105 $ 0 $ 143,826,315 $ (178,806,530) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)   32,158,980        
Stock options and warrants exercised, and vesting of restricted shares 77,811,904 $ 32,159   77,779,745    
Common stock issued for preferred stock dividends (in shares)   920,901        
Common stock issued for preferred stock dividends 1,491,860 $ 922   1,490,938    
Conversion of convertible notes (in shares)   14,449,846        
Conversion of convertible notes 148,977,683 $ 14,450   148,963,233    
Common stock issued for interest on convertible notes (in shares)   328,418        
Common stock issued for interest on convertible notes 1,283,695 $ 328   1,283,367    
Stock-based compensation 2,767,734     2,767,734    
Net loss (210,705,940)       (210,705,940)  
Other comprehensive income 1,100,000         1,100,000
Ending balance (in shares) at Sep. 30, 2020   114,963,145 0      
Ending balance at Sep. 30, 2020 (12,186,174) $ 114,964 $ 0 376,111,332 (389,512,470) 1,100,000
Beginning balance (in shares) at Jun. 30, 2020   89,330,123 0      
Beginning balance at Jun. 30, 2020 (70,476,795) $ 89,330 $ 0 233,715,623 (305,381,748) 1,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)   19,247,746        
Stock options and warrants exercised, and vesting of restricted shares 30,653,505 $ 19,248   30,634,257    
Common stock issued for preferred stock dividends (in shares)   303,617        
Common stock issued for preferred stock dividends 491,860 $ 304   491,556    
Conversion of convertible notes (in shares)   6,065,576        
Conversion of convertible notes 110,242,664 $ 6,066   110,236,598    
Common stock issued for interest on convertible notes (in shares)   16,083        
Common stock issued for interest on convertible notes 294,798 $ 16   294,782    
Stock-based compensation 738,516     738,516    
Net loss (84,130,722)       (84,130,722)  
Other comprehensive income 0          
Ending balance (in shares) at Sep. 30, 2020   114,963,145 0      
Ending balance at Sep. 30, 2020 (12,186,174) $ 114,964 $ 0 376,111,332 (389,512,470) 1,100,000
Beginning balance (in shares) at Dec. 31, 2020   121,922,532 0      
Beginning balance at Dec. 31, 2020 395,204,334 $ 121,923 $ 0 504,112,442 (109,030,031) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)   1,700,343        
Stock options and warrants exercised, and vesting of restricted shares (2,083,046) $ 1,700   (2,084,746)    
Stock-based compensation 3,253,546     3,253,546    
Net loss (245,241,272)       (245,241,272)  
Other comprehensive income (10,200,000)         (10,200,000)
Ending balance (in shares) at Sep. 30, 2021   123,622,875 0      
Ending balance at Sep. 30, 2021 140,933,562 $ 123,623 $ 0 505,281,242 (354,271,303) (10,200,000)
Beginning balance (in shares) at Jun. 30, 2021   123,414,045 0      
Beginning balance at Jun. 30, 2021 222,841,401 $ 123,414 $ 0 506,073,876 (273,155,889) (10,200,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)   208,830        
Stock options and warrants exercised, and vesting of restricted shares (2,013,630) $ 209   (2,013,839)    
Stock-based compensation 1,221,205     1,221,205    
Net loss (81,115,414)       (81,115,414)  
Other comprehensive income 0          
Ending balance (in shares) at Sep. 30, 2021   123,622,875 0      
Ending balance at Sep. 30, 2021 $ 140,933,562 $ 123,623 $ 0 $ 505,281,242 $ (354,271,303) $ (10,200,000)